3D optical reconstruction of in-vitro Glioblastoma brain tumors was evaluated longitudinally with Mesoscopic Fluorescence Molecular Tomography. Tumor growth and tumor response to the Temozolomide, a clinical drug, were evaluated through volumetric change.

© 2016 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription